Industry / France
Reimbursement Reform Under Consideration
December 2007 | Industry NewsFrance's government healthcare advisory body - La Haute Autorité de Santé (HAS) - has concluded that the country should reform the way that chronic diseases are treated.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
